Beyond their effectiveness in glycemic control, these therapies also promote weight loss, making them beneficial for patients with overweight or obesity alongside type 2 diabetes
Patient journey in gastroesophageal reflux disease: real-world perspectives from Italian gastroenterologists, primary care physicians, and ENT specialists
[00:06:00] We are known to have neuroplasticity, and if you repeat something, you're gonna be very good at, if you're learning, I don't know, the multiplication tables or something that you go two by two is four to it
Moreover, liraglutide prevented the degradation of ECM components by downregulating matrix-degrading enzymes, such as MMP-3, suggesting that the GLP-1R agonist modulated the process of reducing the ER stress-related inflammatory response and alleviated the ECM catabolic process